Elevated ferritin expression in microglia and extracellular amyloid-β deposition are associated with reduced

Wolfgang J Streit1, Heidrun Kuhrt1, Ingo Bechmann1

  • 1Institute of Anatomy, Leipzig University, Leipzig, Germany.

Insights

Neuroprotection in late-onset Alzheimer's disease (LOAD) involves ferritin and amyloid-β (Aβ), but is less effective in the temporal lobe. Microglial degeneration may drive neuronal damage in LOAD.

Area of Science:

  • Neuroscience
  • Neuropathology
  • Aging Research

Background:

  • Prior research in preclinical late-onset Alzheimer's disease (LOAD) suggests ferritin and amyloid-β (Aβ) act as neuroprotective mechanisms against iron accumulation.
  • Intracerebral free iron is implicated in aging-dependent neurofibrillary degeneration (NFD).

Purpose of the Study:

  • To enhance understanding of LOAD pathogenesis.
  • To compare neuroprotective mechanisms' effectiveness across brain regions.

Main Methods:

  • Immunohistochemical analysis of NFD, ferritin expression, and Aβ deposition.
  • Comparison across temporal lobe, frontal, and occipital cortices in 34 non-demented human subjects (Braak stages II-III).

Main Results:

  • Ferritin-positive microglia were consistently found in all analyzed brain regions.
  • Aβ deposition preceded NFD in the isocortex, but was absent in 50% of subjects with NFD in the allocortex (temporal lobe).
  • Allocortical NFD included atrophic grid cells and neurofibrillary tangles; isocortical NFD was minimal. Microglial apoptosis coincided with degenerating neurons in the entorhinal cortex.

Conclusions:

  • Neuroprotection via ferritin and Aβ is more effective in the isocortex than the allocortex.
  • Findings support the hypothesis that microglial degeneration or death promotes neuronal degeneration in LOAD.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...